Skip to main content
UniHealth

Doctor search

Anthony Cozzolino, MD

Forensic Psychiatry · San Jose

NPI 1437355948

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Office
1

Offices

1 location

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cozzolino’s office at (408) 494-1570 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A65094 · Current

Licensed to practise in California · since 1998 · expires 2027-09-30 · Rosalind Franklin University, the Chicago Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Psychiatry and Neurology - Forensic Psychiatry

Drugs they prescribed that Part D paid

$46,968

Pharmacies billed $46,968 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 38) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

23 generic and 15 brand-name prescriptions · $46,968 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Aristada13$45,519$3,501

Year by year

Part D prescribing by year
202438None0% (0)39%$46,968
202354None0% (0)50%$61,364
202237None0% (0)68%$56,141
202149None0% (0)41%$15,017
202068None0% (0)19%$20,712
201978None0% (0)None$19,320
201887None0% (0)15%$18,238
2017176None0% (0)12%$21,470
2016250NoneNone6%$22,610
201594None0% (0)0%$7,260
201459None0% (0)31%$10,481
201312None0% (0)None$1,419

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 2 drugs

Part D drugs prescribed in 2023
Aristada13$51,446$3,957
Lorazepam12$101$8

2022: 1 drug

Part D drugs prescribed in 2022
Aristada12$42,656$3,555

2021: 1 drug

Part D drugs prescribed in 2021
Lexapro12$5,021$418

2020: 4 drugs

Part D drugs prescribed in 2020
Guanfacine Hcl Er11$187$17
Aripiprazole11$148$13
Lorazepam15$107$7
Escitalopram14$92$7

2019: 4 drugs

Part D drugs prescribed in 2019
Aripiprazole13$2,860$220
Escitalopram24$662$28
Guanfacine Hcl Er14$369$26
Lorazepam14$93$7

2018: 5 drugs

Part D drugs prescribed in 2018
Abilify12$13,848$1,154
Aripiprazole11$3,351$305
Escitalopram26$494$19
Guanfacine Hcl Er11$330$30
Lorazepam16$28$2

2017: 5 drugs

Part D drugs prescribed in 2017
Abilify18$18,340$1,019
Aripiprazole11$778$71
Escitalopram16$86$5
Sertraline14$44$3
Lorazepam25$35$1

2016: 13 drugs

Part D drugs prescribed in 2016
Clozapine27$7,789$288
Aripiprazole12$4,829$402
Divalproex Sodium Er14$981$70
Methylphenidate11$449$41
Risperidone13$380$29
Bupropion Xl12$337$28
Haloperidol11$278$25
Benztropine Mesylate21$193$9
Oxcarbazepine11$167$15
Sertraline25$117$5
Metformin14$100$7
Buspirone11$30$3
Lorazepam16$23$1

2015: 2 drugs

Part D drugs prescribed in 2015
Clozapine16$4,386$274
Benztropine Mesylate11$85$8

2014: 2 drugs

Part D drugs prescribed in 2014
Latuda11$7,764$706
Risperidone14$146$10

Money from drug and device companies

$1,106 in 2025

Industry payments by year
2025411None$1,106
202434None$407
202324None$472
202222None$123
202011None$99
201948None$935

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Neurocrine BioSciencesIngrezza$360
3 payments
  • Meals for Ingrezza · 2025-05-20 · $170
  • Meals for Ingrezza · 2025-05-20 · $20
  • Meals for Ingrezza · 2025-02-20 · $170
Janssen Scientific AffairsInvega Sustenna$336
3 payments
  • Meals for Invega Sustenna · 2025-12-17 · $102
  • Meals for Invega Sustenna · 2025-09-02 · $119
  • Meals for Invega Sustenna · 2025-05-19 · $115
Otsuka Pharmaceutical Development & CommercializationRexulti$297
4 payments
  • Meals for Rexulti · 2025-11-12 · $134
  • Meals · 2025-10-22 · $90
  • Meals for Abilify Asimtufii · 2025-05-28 · $64
  • Meals for Abilify Asimtufii · 2025-05-28 · $10
AlkermesAristada$113
1 payment
  • Meals for Aristada · 2025-10-01 · $113
See all 11 published payments
Every published payment
Janssen Scientific AffairsMeals · 2025-12-17Invega Sustenna$102
Otsuka Pharmaceutical Development & CommercializationMeals · 2025-11-12Rexulti$134
Otsuka Pharmaceutical Development & CommercializationMeals · 2025-10-22None$90
AlkermesMeals · 2025-10-01Aristada$113
Janssen Scientific AffairsMeals · 2025-09-02Invega Sustenna$119
Otsuka Pharmaceutical Development & CommercializationMeals · 2025-05-28Abilify Asimtufii$64
Otsuka Pharmaceutical Development & CommercializationMeals · 2025-05-28Abilify Asimtufii$10
Neurocrine BioSciencesMeals · 2025-05-20Ingrezza$170
Neurocrine BioSciencesMeals · 2025-05-20Ingrezza$20
Janssen Scientific AffairsMeals · 2025-05-19Invega Sustenna$115
Neurocrine BioSciencesMeals · 2025-02-20Ingrezza$170
See earlier years (2024, 2023, 2022, 2020, 2019)

2024: $407

Payments by company in 2024
Janssen Scientific AffairsInvega Sustenna$188
2 payments
  • Meals for Invega Sustenna · 2024-08-16 · $105
  • Meals for Spravato · 2024-02-27 · $83
Otsuka Pharmaceutical Development & CommercializationAbilify Asimtufii$116
1 payment
  • Meals for Abilify Asimtufii · 2024-01-17 · $116
AlkermesLybalvi$103
1 payment
  • Meals for Lybalvi · 2024-07-11 · $103

2023: $472

Payments by company in 2023
Janssen Scientific AffairsSpravato$236
2 payments
  • Meals for Spravato · 2023-06-28 · $149
  • Meals for Invega Sustenna · 2023-05-23 · $87
AlkermesLybalvi$235
2 payments
  • Meals for Lybalvi · 2023-10-10 · $120
  • Meals for Aristada · 2023-04-04 · $115

2022: $123

Payments by company in 2022
Janssen Scientific AffairsSpravato$66
1 payment
  • Meals for Spravato · 2022-02-03 · $66
Neurocrine BiosciencesIngrezza$56
1 payment
  • Meals for Ingrezza · 2022-02-17 · $56

2020: $99

Payments by company in 2020
Neurocrine BiosciencesIngrezza$99
1 payment
  • Meals for Ingrezza · 2020-02-13 · $99

2019: $935

Payments by company in 2019
Janssen Scientific AffairsSpravato$477
4 payments
  • Meals for Spravato · 2019-11-05 · $123
  • Meals for Spravato · 2019-08-07 · $124
  • Meals for Spravato · 2019-05-21 · $125
  • Meals for Invega Trinza · 2019-01-28 · $106
AlkermesAristada$248
2 payments
  • Meals for Aristada · 2019-12-18 · $121
  • Meals for Aristada · 2019-04-25 · $127
IndiviorPerseris$119
1 payment
  • Meals for Perseris · 2019-09-17 · $119
Neurocrine BiosciencesIngrezza$90
1 payment
  • Meals for Ingrezza · 2019-02-25 · $90

Professional record

NPI
1437355948
Licence
CA A65094California A65094: Current · expires 2027-09-30
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 2084F0202X (2084F0202X)
Mailing address
614 Tully Rd, San Jose, CA, 95111
NPI first listed
2007-06-22
NPI last updated
2013-03-21

This is when the NPI record was last certified, not a medical board exam.